Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
1.09
Dollar change
0.00
Percentage change
0.00
%
IndexRUT P/E- EPS (ttm)-2.78 Insider Own12.58% Shs Outstand34.90M Perf Week3.32%
Market Cap38.10M Forward P/E- EPS next Y-1.58 Insider Trans0.00% Shs Float30.56M Perf Month-37.71%
Income-107.49M PEG- EPS next Q-0.45 Inst Own75.05% Short Float4.49% Perf Quarter-43.52%
Sales0.00M P/S- EPS this Y18.23% Inst Trans-6.56% Short Ratio2.55 Perf Half Y-69.30%
Book/sh2.74 P/B0.40 EPS next Y36.51% ROA-69.76% Short Interest1.37M Perf Year-93.74%
Cash/sh2.80 P/C0.39 EPS next 5Y- ROE-80.13% 52W Range0.92 - 27.35 Perf YTD-95.61%
Dividend Est.- P/FCF- EPS past 5Y-12.39% ROI-109.57% 52W High-96.01% Beta0.07
Dividend TTM- Quick Ratio9.90 Sales past 5Y-36.87% Gross Margin- 52W Low18.32% ATR (14)0.18
Dividend Ex-Date- Current Ratio9.90 EPS Y/Y TTM3.64% Oper. Margin- RSI (14)39.14 Volatility11.44% 14.26%
Employees131 Debt/Eq0.05 Sales Y/Y TTM-100.00% Profit Margin- Recom3.00 Target Price2.50
Option/ShortYes / Yes LT Debt/Eq0.03 EPS Q/Q42.06% Payout- Rel Volume0.25 Prev Close1.09
Sales Surprise- EPS Surprise18.92% Sales Q/Q- EarningsNov 12 BMO Avg Volume537.93K Price1.09
SMA20-4.82% SMA50-34.69% SMA200-72.77% Trades Volume135,597 Change0.00%
Date Action Analyst Rating Change Price Target Change
Nov-13-24Downgrade Stifel Buy → Hold $7 → $2
Nov-11-24Downgrade Piper Sandler Overweight → Neutral $8 → $2
Nov-11-24Downgrade JP Morgan Neutral → Underweight
May-14-24Downgrade Wolfe Research Outperform → Peer Perform
May-10-24Downgrade Guggenheim Buy → Neutral
May-10-24Downgrade Barclays Overweight → Equal Weight $13 → $4
Feb-22-24Downgrade UBS Buy → Neutral $61 → $10
Feb-21-24Downgrade Leerink Partners Outperform → Market Perform $42 → $10
Feb-21-24Downgrade JP Morgan Overweight → Neutral $35 → $15
Feb-21-24Downgrade H.C. Wainwright Buy → Neutral
Nov-12-24 08:00AM
Nov-11-24 12:18PM
08:00AM
Sep-29-24 07:57AM
Sep-25-24 11:34AM
08:00AM Loading…
Aug-08-24 08:00AM
Jun-21-24 01:13AM
Jun-14-24 09:35AM
May-29-24 09:35AM
May-14-24 07:08AM
May-13-24 09:35AM
May-10-24 03:46PM
07:55AM
07:54AM
May-09-24 04:12PM
03:59PM Loading…
03:59PM
02:31PM
01:53PM
08:00AM
Apr-09-24 12:00PM
06:31AM
Mar-22-24 05:39AM
Mar-07-24 02:52PM
08:36AM
08:00AM
Mar-05-24 04:30PM
Feb-20-24 04:03PM
11:22AM
07:58AM
07:39AM
07:30AM Loading…
07:30AM
07:17AM
Feb-13-24 08:00AM
Jan-31-24 08:00AM
Jan-02-24 08:00AM
Nov-27-23 08:00AM
Nov-14-23 07:41PM
Nov-13-23 08:00AM
Nov-03-23 12:00PM
Nov-01-23 04:05PM
Oct-18-23 09:00AM
Sep-27-23 09:24PM
Sep-14-23 09:44AM
Aug-30-23 04:05PM
Aug-16-23 09:55AM
Aug-11-23 08:00AM
Aug-09-23 10:26AM
Aug-08-23 06:03AM
Jun-07-23 08:00AM
May-25-23 05:00PM
May-11-23 08:00AM
May-03-23 08:00AM
Apr-26-23 04:19PM
Mar-29-23 08:00AM
Mar-21-23 08:50AM
Mar-14-23 08:00AM
Mar-02-23 10:00AM
Feb-28-23 08:00AM
Feb-27-23 09:55AM
Feb-23-23 08:50AM
Feb-22-23 06:31AM
Feb-16-23 04:02AM
Feb-10-23 09:55AM
Feb-07-23 08:00AM
Jan-31-23 05:43PM
Jan-25-23 08:50AM
Jan-03-23 08:00AM
Dec-30-22 09:55AM
Dec-17-22 08:56AM
Dec-08-22 06:30AM
Nov-30-22 07:05PM
Nov-22-22 08:46AM
Nov-17-22 09:38PM
04:24PM
09:55AM
Nov-12-22 07:42AM
Nov-10-22 09:15AM
08:00AM
Nov-09-22 08:00AM
Oct-12-22 07:50AM
Sep-28-22 08:00AM
Sep-23-22 12:00PM
09:55AM
Sep-15-22 06:17AM
Sep-01-22 09:55AM
Aug-31-22 08:00AM
Aug-16-22 09:55AM
Aug-11-22 09:15AM
08:00AM
Jul-10-22 09:37AM
Jun-20-22 09:25AM
May-25-22 03:01PM
08:00AM
May-23-22 08:00AM
May-11-22 09:15AM
08:00AM
May-09-22 05:15PM
May-05-22 09:25AM
May-04-22 08:00AM
Apr-11-22 08:29AM
Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Brockstedt Dirk G.CHIEF SCIENTIFIC OFFICERJan 05 '24Sale22.7889820,45627,820Jan 08 05:50 PM
Brockstedt Dirk G.Chief Scientific OfficerDec 29 '23Option Exercise6.188,00049,44027,070Jan 02 04:29 PM
HO WILLIAMChief Medical OfficerDec 21 '23Sale21.682,50054,20015,020Dec 22 02:31 PM